Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
HIV, hepatitis and opioids take a toll on West Virginia. $2.4 million in federal aid arrives amid battles over syringe exchanges.
The advocacy grants allow groups in Indiana and Oklahoma to expand services including HIV, hepatitis C and syringe exchange programs.
Chronic pain is common among people with HIV, but it may not drive opioid use disorder.
The Viral Hepatitis National Strategic Plan for the United States, released by HHS, offers a road map for the next five years.
These Florida and Maryland communities can access HIV tests, PrEP and overdose prevention via an RV and a van.
The Act Now: End AIDS Coalition outlines how the Biden-Harris team can address the HIV, STI, viral hepatitis and overdose syndemics.
But is it enough? And what about support for syringe services?
A West Virginia drive-through event does exactly that—plus give free Naloxone trainings.
A $7 million grant goes to new research seeking insights to neurological and cognitive problems.
People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.
Overdose deaths rose by nearly 5% in 2019, and the pandemic could make matters worse.
Infective endocarditis is a life-threatening bacterial infection of the heart valves that is associated with injection drug use.
This is one of many ways that people who use drugs can engage in harm reduction during the coronavirus pandemic.
A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections
A survey of local health departments reveals concerning news—and a silver lining.
A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.